Simcere Pharmaceutical Group Limited (2096.HK)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jinsheng Ren | Co-Founder, Chairman & CEO | 3.12M | -- | 1962 |
Mr. Yushan Wan | CFO, Joint Company Secretary & Executive Director | 7.48M | -- | 1970 |
Mr. Renhong Tang Ph.D. | Executive Director | 14.53M | -- | 1980 |
Mr. Gaobo Zhou | Chief Investment Officer | -- | -- | 1979 |
Mr. Quanfu Feng | Vice President of Marketing | -- | -- | 1965 |
Dr. Bijoyesh Mookerjee M.D. | Chief Medical Officer of Oncology | -- | -- | 1962 |
Mr. Danny Chen Ph.D. | Senor Vice President | -- | -- | 1968 |
Mr. Tong Zhu | Chief Operating Officer of Simcere Zaiming | -- | -- | 1978 |
Dr. Tamas Oravecz Ph.D. | Senior VP & Chief Scientific Officer of U.S. | -- | -- | -- |
Ms. Xi Wang | VP & Executive Director | -- | -- | 1983 |
Simcere Pharmaceutical Group Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 7,027
Description
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. The company focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN, a simnotrelvir tablets/ritonavir tablets. The company also offers promotion services for pharmaceutical products. It has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize SIM0801 and other drugs in the Greater China region. In addition, the company engages in the manufacture of pharmaceutical ingredients; and property management business. Simcere Pharmaceutical Group Limited was founded in 1995 and is headquartered in Nanjing, China.
Corporate Governance
Recent Events
Recent Events Information Not Available
Upcoming Events
Jun 18, 2024
Ex-Dividend Date